MiR-371a-5p Positively Associates with Hepatocellular Carcinoma Malignancy but Sensitizes Cancer Cells to Oxaliplatin by Suppressing BECN1-Dependent Autophagy

Oxaliplatin (OXA)-based chemotherapy demonstrates active efficacy in advanced hepatocellular carcinoma (HCC), while resistance development limits its clinical efficacy. Thus, identifying resistance-related molecules and underlying mechanisms contributes to improving the therapeutic efficacy of HCC p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Zhenbing, Qiu, Xin, Jin, Pu, Li, Zhaodong, Zhang, Yan, Lv, Lei, Song, Fangzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604925/
https://www.ncbi.nlm.nih.gov/pubmed/36295086
http://dx.doi.org/10.3390/life12101651